Concerned over possible hike in medicine prices: Jena
November 29th, 2011 - 6:50 pm ICT by IANSNew Delhi, Nov 29 (IANS) The government Tuesday expressed its concern over a likely increase in prices of medicines by international companies which are eyeing Indian firms after being allowed investment up to 100 percent of capital in the sector.
“The apprehension amongst policy makers is that if five or 10 foreign companies take over production bases in India through the 100 percent FDI route, it would give rise to monopolies, which would be able to dictate prices of common drugs,” Srikant Kumar Jena, chemicals and fertilisers minister, said at an industry event here.
Jena was speaking at a Federation of Indian Chambers of Commerce and Industry (FICCI) event.
“The acquiring companies need to clearly demonstrate the value addition brought forth, either for servicing the domestic segment or significant increases in export earnings,” Jena said.
“The motive should not merely be shopping of Indian companies to access one of the highest growth markets in India or to acquire facilities and reduce competition of potential Indian pharma industry in its quest for access to emerging export markets,” he said.
Pharma industry representatives also expressed their apprehensions about a proposed price monitoring system by the government saying it would constrain growth of the sector.
Jena was quick to clarify that only the prices of “most essential drugs” would be under surveillance.
“Unlike the FMCG, medicines are not available in a free market as the prescription of a doctor drives the market and there is an asymmetry due to the interests of various stakeholders,” Jena said.
Jena said the issue impacted not just India but also developed countries.
“This is an issue that is engaging the attention of governments of even developed countries, where a well-developed insurance sector and more informed public is also finding it difficult to contain costs of medicines and overall healthcare.”
Under the current framework, foreign direct investment (FDI) up to 100 percent under automatic route in greenfield investments is allowed; FDI up to 100 percent in existing companies is allowed under government approval route.
- Automatic approval to FDI in greenfield pharma projects to continue: RBI - Dec 12, 2011
- Foreign investment in pharma to face competition check - Oct 11, 2011
- Regulate foreign investment for cheaper medicines: Azad - Nov 01, 2010
- 24 percent cap on FDI by international airlines proposed - Nov 17, 2011
- India allows FDI in limited liability partnership firms - May 24, 2011
- Competition check for FDI in pharma will help consumers: CUTS - Oct 11, 2011
- Government looking at FDI in multi-brand retail: Sharma - Apr 27, 2010
- Indian industry split on FDI cap in defence manufacturing? (Lead) - Jul 26, 2010
- FDI in defence should not be raised to 100 percent: CII - May 09, 2010
- Decision on aviation FDI deferred for next cabinet meet - Apr 12, 2012
- Foreign direct investment norms eased for Limited Liability partnerships - May 11, 2011
- Recall of retail FDI regressive, disappointing: India Inc (Roundup) - Dec 07, 2011
- 'Proposal for FDI in domestic carriers sent to commerce ministry' - Feb 23, 2012
- Focus on rationalising sales tax on ATF: CII - Feb 05, 2012
- PM to meet airline chiefs Saturday (Lead) - Nov 25, 2011
Tags: access one, apprehension, apprehensions, asymmetry, chambers of commerce, chambers of commerce and industry, domestic segment, export earnings, export markets, fertilisers, growth markets, indian chambers of commerce, indian pharma industry, industry representatives, insurance sector, jena, medicine prices, monitoring system, monopolies, value addition